Methylene diphosphonate
Jump to navigation
Jump to search
| File:Medronic acid.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | CH6O6P2 |
| Molar mass | 176.002 g/mol |
Methylene diphosphonate (MDP or medronic acid) is a pharmaceutical product used especially in nuclear medicine, linked to 99mTc, as a marker to avoid the Single Photon Emission Scintigraphy, or SPECT, to localize carcinogentic bone metastasis as well as other diseases that can alter the natural turn-over in bone.
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Bisphosphonates